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S U M M A R Y
Background: After an absence of 29 years, dengue virus type 3 (DENV-3) re-emerged in Guangzhou in
2009 and again in 2010. However, the geographical route by which the virus entered the city, and how it
has changed genetically, remain unclear. Therefore, we carried out a comprehensive investigation into
the molecular characteristics of the DENV-3 involved.
Methods: The envelope (E) genes of viruses isolated from dengue patients during the 2009–2010
epidemics were sequenced and compared with previously published E gene sequences of global
representative DENV-3 strains available in GenBank, including isolates circulating in other provinces of
China.
Results: A total of 13 isolates (seven from 2009 and six from 2010) were obtained from human serum
samples. Phylogenetic analysis revealed that the isolates were grouped into three genotypes (I, III, and V)
and then two clades within genotype III (genotype I from Indonesia, genotype III clade A from Coˆte
d’Ivoire, genotype III clade B from Tanzania, and genotype V from Philippines). In addition, there were
1.3–9.0% and 0.5–3.9% differences in the nucleic and deduced amino acid sequences between the 2009
and 2010 strains, respectively.
Conclusions: The DENV-3 viruses from the period 2009–2010 were not from the continuous spread of an
epidemic strain or the re-emergence of the 2009 strains in the 2-year period. The introduction of
different DENV-3 genotypes following more than one geographical route was an important contributing
factor to the 2009–2010 dengue epidemics in Guangzhou.
 2013 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
The causative agents of dengue disease are four antigenically
distinct viruses designated dengue virus types 1–4 (DENV 1–4),
belonging to the genus Flavivirus, family Flaviviridae. The DENV
genome consists of a single-stranded, non-segmented, positive-
sense RNA molecule roughly 10.7 kb in size.1 Infection with one of
the four DENV serotypes can be asymptomatic or trigger a wide
spectrum of clinical manifestations, ranging from mild acute
febrile illness to classical dengue fever (DF) and to severe dengue
hemorrhagic fever (DHF)/dengue shock syndrome (DSS).2
During the last two decades, the increase in incidence and the
geographical expansion of dengue have been facilitated by the rapid
movement of viruses and vectors through international air travel
and trade, uncontrolled urbanization, modern transportation, and
population ﬂow.3–7 Dengue is currently the most important* Corresponding author. Tel.: +86 20 36055861; fax: +86 20 36055827.
E-mail address: yangzc@gzcdc.org.cn (Z.-c. Yang).
1 Three authors contributed equally to this paper.
1201-9712/$36.00 – see front matter  2013 Published by Elsevier Ltd on behalf of In
http://dx.doi.org/10.1016/j.ijid.2012.12.017arthropod-borne viral disease in the world. Some 2.5 billion people
living in tropical and sub-tropical regions are at risk of dengue
infection, which equates to about 40% of humanity.8,9 An estimated
100 million infections occur annually, with 500 000 DHF/DSS cases
and more than 25 000 deaths, mostly among children.10
In China, historical epidemics of dengue-like illness were
documented before 1950. However, etiological and epidemiologi-
cal investigations were not carried out during these epidemics.
After a 28-year period without dengue cases between 1950 and
1978, a DENV-4 outbreak occurred in the city of Foshan
(contiguous with Guangzhou) in 1978,11 which started the
epidemic of dengue in southern China.12 In August 1978, dengue
infections ﬁrst spread to Guangzhou from Foshan. Since then,
highly localized and relatively sporadic yearly outbreaks have been
reported in Guangzhou. Until now, a cumulative total of nearly
20 000 dengue cases have been identiﬁed in Guangzhou,
accounting for 67% of all reported cases in Guangdong Province
and 56% in mainland China.13
Serotypes DENV-1, DENV-2, DENV-3, and DENV-4 circulated
sequentially in Guangzhou between 1978 and 2008.13 Beginning in
2000, outbreaks of DENV in Guangzhou were due to DENV-1 only,ternational Society for Infectious Diseases.
Table 1
Primers used for ampliﬁcation and sequencing of the complete DENV-3 envelope
gene
Reaction Primer name Sequence (from 50 to 30) Position
Ampliﬁcation D3E1F AGACATTGACTGGTGGTGC 622–640
Ampliﬁcation D3E1R TGATGACGGTGTATTTGAGG 1336–1355
Ampliﬁcation D3E2F CGGTTGTGGTTTGTTTGG 1243–1260
Ampliﬁcation D3E2R CTGCGTTTCTGAGACTTCTTTC 1855–1876
Ampliﬁcation D3E3F TACCGCACTGACAGGAGC 1711–1728
Ampliﬁcation D3E3R CCACAACTACCGTTAATTTGAT 2663–2684
Sequencing D3-Seq1S GCTGGTTACCCCATCCA 912–930
Sequencing D3-Seq2S AGGAGCAGGACCAGAAC 1185–1202
Sequencing D3-Seq3S CTGAATATGGAACCCTCG 1455–1473
Sequencing D3-Seq5S GTGACCAAGAAGGAGGA 2000–2017
Sequencing D3-Seq2C GCCATCTTGGGAGACA 2165–2181
Sequencing D3-Seq6C CAGCTGGCGACCCTAA 1088–1104
Sequencing D3rI GGCAACAGCCATTGCAGGC 2539–2558
DENV-3, dengue virus type 3.
Table 2
DENV-3 strains newly isolated in Guangzhou during 2009–2010
Strain Date of occurrence GenBank accession number District
09/GZ/1081 2/28/2009 Hm466962 Yuexiu
09/GZ/1483 3/18/2009 Hm466963 Haizhu
09/GZ/10806 7/22/2009 Hm466965 Haizhu
09/GZ/10616 7/25/2009 Hm466964 Yuexiu
09/GZ/11144 8/6/2009 Hm466966 Yuexiu
09/GZ/11194 8/6/2009 Hm466967 Yuexiu
09/GZ/13105 9/8/2009 Hm466968 Haizhu
10/GZ/4898 4/25/2010 JN009093 Yuexiu
10/GZ/5536 5/12/2010 JN009094 Nansha
10/GZ/9119 8/05/2010 JN009095 Baiyun
10/GZ/9534 8/12/2010 JN009096 Baiyun
10/GZ/9721 8/22/2010 JN009097 Baiyun
10/GZ/10549 9/11/2010 JN009098 Panyu
DENV-3, dengue virus type 3.
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since 1980.14 In 2010, DENV-3 was isolated again in Guangzhou,
producing a larger outbreak that affected ﬁve districts of the city of
Guangzhou (Total of 12 districts). As the origin of these outbreaks
was not determined through epidemiological investigation, the
question arose again as to whether the dengue had become
endemic in Guangzhou. To understand the molecular epidemiolo-
gy of DENV-3 in Guangzhou, and also particularly to determine
whether the 2009 and 2010 outbreaks were caused by the same
viral genotype, the complete envelope (E) gene sequences of
isolates from both years were determined.
2. Materials and methods
The following is a brief outline of the methods employed in the
present study. Additional details are provided by Luo et al.,13 Jing
et al.,15 and Zheng et al.16
2.1. Patients and samples
A total of 55 clinically diagnosed cases were identiﬁed from
passive surveillance or recognized by active searches during the
2009–2010 dengue epidemics/outbreaks in Guangzhou. In each
case, 8 ml of peripheral venous blood was collected in plasma
separator gel tubes during the acute phrase and taken to the
laboratory for analysis within 6 h of collection. The present study
was approved by the Ethics Committee of the Guangzhou Center
for Disease Control and Prevention. Written informed consent was
obtained from all patients upon seeking medical services or before
entry into the study.
2.2. Virus strains
In brief, 17 serum samples were found to be positive for DENV
RNA by real-time PCR (RT-PCR)16 and 13 isolates were identiﬁed as
DENV-3. These strains were inoculated into C6/36 Aedes albopictus
mosquito cells17 for passaging, and cell supernatants were
preserved at 80 8C until RNA extraction.
2.3. RNA extraction and reverse transcriptase PCR
Viral RNA was extracted from 200 ml of DENV-3-infected C6/C36
culture supernatant using the QIAamp Viral RNA Mini Kit (Qiagen,
Hilden, Germany) in accordance with the manufacturer’s instruc-
tions. Ampliﬁcation of the E gene was then performed using the One-
Step Reverse Transcriptase-PCR Kit (TaKaRa, Shiga, Japan) and three
manually designed oligonucleotide primer pairs (Table 1 for details)
in order to produce three overlapping fragments covering the
complete E gene. Brieﬂy, the reverse transcriptase PCR program
consisted of a reverse transcription step at 50 8C for 30 min and the
denaturation of reverse transcriptase enzyme at 95 8C for 10 min,
followed by the PCR reaction performed for three cycles at 94 8C for
1 min, 60 8C for 40 s, 72 8C for 1 min, 35 cycles at 94 8C for 30 s, 55 8C
for 30 s, and 72 8C for 40 s, and a ﬁnal 72 8C for 3 min.
2.4. Sequencing and phylogenetic analysis
Ampliﬁed cDNA products of DENV-3 were sequenced directly
after puriﬁcation using a QIAquick PCR Puriﬁcation Kit (Qiagen,
Germany). Double-stranded sequencing of the E gene was
performed on an ABI PRISM 3700 Genetic Analyzer (Applied
Biosystems) using an ABI PRISM BigDye Terminator Cycle
Sequencing Ready Reaction Kit (Applied Biosystems, USA) in
accordance with the manufacturer’s protocol. DENV primers used
for sequencing were designed on the basis of published DENV
sequences and are presented in Table 1. The assemblies ofsequences were created with SeqMan II software (DNASTAR,
Inc., Madison, WI, USA).15 Percent nucleotide and amino acid
sequence identities were calculated using the BLAST engine
(http://www.ncbi.nlm.nih.gov/Entrez/).18 Multiple sequence
alignment was carried out using Clustal X v.1.83 software.16
Phylogenetic trees were constructed by the neighbor-joining and
maximum likelihood methods with a Kimura two-parameter
model using MEGA 4.0 software (Molecular Evolutionary Genetics
Analysis, version 4.0; http://www.megasoftware.net/mega4/
mega.html).15 One thousand bootstrap repetitions were calculated
for placing conﬁdence values on groupings within trees. DENV-1
strain D1/USA/Hawaii/1945 (GenBank accession number
AF425619) was used as out-group to root the trees.
3. Results
We determined the complete E gene nucleotide sequences of
the 13 DENV-3 strains (seven from 2009 and six from 2010) from
Guangzhou. The sequences of all the strains reported in this paper
have been deposited in GenBank under the accession numbers
listed in Table 2.
3.1. Comparison of nucleic and amino acid sequences
The percentages of nucleotide and amino acid identities of the
complete E gene among the 13 different DENV-3 strains are shown
in Table 3. With the exception of 10/GZ/10549, the ﬁve other
DENV-3 isolates from the 2010 epidemic area displayed high
similarity, with 99.5–100% and 98.7–100% sequence identity in
nucleotide and amino acid sequences, respectively. Three DENV-3
isolates (09/GZ/1483, 09/GZ/10806, and 09/GZ/1081) from the
Table 3
Percentage identity within the complete E genomic sequences of 13 different DENV-3 strains obtained from Guangzhou, during 2009–2010
Pairwise amino acid identity (%)
No. Strain 1 2 3 4 5 6 7 8 9 10 11 12 13
1 10/GZ/4898 - 1 0.987 1 1 0.967 0.969 0.967 0.995 0.969 0.993 0.993 0.985
2 10/GZ/5536 1 - 0.987 1 1 0.967 0.969 0.967 0.995 0.969 0.993 0.993 0.985
3 10/GZ/9119 0.995 0.995 - 0.987 0.987 0.955 0.957 0.957 0.983 0.957 0.981 0.981 0.973
4 10/GZ/9534 1 1 0.995 - 1 0.967 0.969 0.967 0.995 0.969 0.993 0.993 0.985
5 10/GZ/9721 1 1 0.995 1 - 0.967 0.969 0.967 0.995 0.969 0.993 0.993 0.985
6 10/GZ/10549 0.911 0.911 0.907 0.911 0.911 - 0.973 0.971 0.971 0.973 0.969 0.969 0.961
7 09/GZ/1081 0.934 0.934 0.930 0.934 0.934 0.936 - 0.997 0.973 1 0.971 0.971 0.963
8 09/GZ/1483 0.933 0.933 0.930 0.933 0.933 0.935 0.998 - 0.971 0.997 0.969 0.969 0.961
9 09/GZ/10616 0.987 0.987 0.983 0.987 0.987 0.916 0.938 0.937 - 0.973 0.997 0.997 0.989
10 09/GZ/10806 0.934 0.934 0.930 0.934 0.934 0.936 1 0.998 0.938 - 0.971 0.971 0.963
11 09/GZ/11144 0.985 0.985 0.981 0.985 0.985 0.913 0.937 0.935 0.997 0.937 - 1 0.991
12 09/GZ/11194 0.985 0.985 0.981 0.985 0.985 0.914 0.937 0.936 0.997 0.937 0.999 - 0.991
13 09/GZ/13105 0.981 0.981 0.977 0.981 0.981 0.910 0.933 0.932 0.993 0.933 0.995 0.995 -
Pairwise nucleotide identity (%)
DENV-3, dengue virus type 3.
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than 99.7% sequence identity in both nucleotide and amino acid
sequences. Three other 2009 DENV-3 isolates, including 09/GZ/
10616, 09/GZ/11144, and 09/GZ/11194 strains, showed rela-
tively lower sequence identity compared with the 09/GZ/13105
isolate (99.3–99.5% nucleotide and 98.9–99.1% amino acid
sequence identity). However, differences in the nucleotide and
deduced amino acid sequences between the 2009 and 2010
strains were found to be 1.3–9.0% and 0.5–3.9%, respectively,
which suggested that the 13 isolates might have originated from
different regions. Further phylogenetic analysis revealed that
these viruses belong to different genotypes (see below for
details).
3.2. Phylogenetic analysis
Sequences available in GenBank and corresponding to strains
belonging to all major branches of previously published DENV-3
phylogenies (see Table 4 for details) were included in this analysis
and selected to maximize the representation of genotypes, regions,
and years of isolation. However, isolates that showed higher
nucleotide sequence homology but were adequately represented
were removed from the analysis. Hence, the ﬁnal tree only
included representative local samples for each genotype. The trees
derived from the neighbor-joining method and the maximum
likelihood method were very similar to each other. Thus, only the
tree from the neighbor-joining method based on the complete E
gene sequences is shown.
Five genetic subtypes, each representing a distinct genotype,
could be distinguished, as shown in Figure 1: one containing virus
isolated in Indonesia, Malaysia, Singapore, Philippines, and the
South Paciﬁc (genotype I); the second including viruses collected
from Thailand, Myanmar, Cambodia, and China (genotype II); the
third including a large array of viruses sampled from Southeast
Asia, Central and South America, Africa, and the Middle East
(genotype III); the fourth, the most divergent group, containing
virus from Puerto Rico from the 1960s/1970s (genotype IV); and
the ﬁfth represented by the oldest strain, isolated in the Philippines
in 1956 (genotype V).
Phylogenetically, as demonstrated in Figure 1, 13 newly
identiﬁed DENV-3 isolates were characterized into genotypes I,
III, and V. Only one DENV-3 strain (10/GZ/10549) from 2010
belonged to genotype I and clustered closely with strains isolated
from 2004 to 2007 in Indonesia. Three 2009 isolates (09/GZ/1081,
09/GZ/1483, and 09/GZ/10806) clustered together as genotype V,
which was closely related to the strain from Guangxi China in
1980.Within Guangzhou genotype III strains, two clusters (A and B) of
nine isolates were observed. Clade A contained four 2009 strains
(09/GZ/11144, 09/GZ/11194, 09/GZ/10616, and 09/GZ/13105).
Five other DENV-3 isolates (10/GZ/4898, 10/GZ/5536, 10/GZ/
9119, 10/GZ/9534, and 10/GZ/9721) from 2010 outbreaks clus-
tered together and fell into clade B. They resided in the
phylogenetic tree much closer to the isolate from Tanzania in 2010.
4. Discussion
DENV-3 was initially isolated during an outbreak in 1956 in
Philippines,19 and since then the size of the geographic range and
the incidence of this serotype have increased substantially
worldwide.11,20–23 To date, DENV-3 has been subdivided into four
to ﬁve genotypes.24,25 Genotypes I–III are responsible for most
DENV-3 infections and have been associated with DF/DHF
epidemics in Southeast Asia, the Indian subcontinent, East Africa,
and the Americas. In contrast, genotypes IV and V are only found in
a few older strains.20,26 Genotype IV, representing the earlier
strains from Puerto Rico, has not been isolated for about 40 years.
Genotype V, represented by the H87 strain from Philippines in
1956 and other early isolates from Asia, has also rarely been
associated with dengue epidemics.
The recent emergence of DENV-3 in Guangzhou occurred after a
decade of active DENV-1 circulation, about 29 years after the
previous report of DENV-3 in the region.13 In order to complement
the epidemiological data and arrive at a better understanding of
the geographical route that allowed the virus entry and spread in
Guangzhou, we conducted a phylogenetic analysis on the complete
E gene of DENV-3 strains newly isolated during the 2009–2010
epidemics/outbreaks.
The resulting phylogenetic tree shows that all 13 DENV-3
strains were grouped into three genotypes (I, III, and V) (Figure 1).
As previously described,27 two genotypes (III and V) of DENV-3
were co-circulating in Guangzhou in 2009. However, 2009 and
2010 genotype III strains were segregated into two different clades
(clade A and clade B). With regard to clade A strains (09/GZ/11144,
09/GZ/11194, 09/GZ/10616, and 09/GZ/13105) isolated from
Guangzhou in 2009, it was previously deemed that they were
clustered with epidemic strains in India in 2008.27 However we
deduced that they were more closely related to a previously
reported strain from Coˆte d’Ivoire isolated in 2008.28 Inconsistent
results may be related to the biased conclusion resulting from the
smaller number of strains included in the previous study. Five 2010
strains (10/GZ/4898, 10/GZ/5536, 10/GZ/9119, 10/GZ/9534, and
10/GZ/9721) are nearly identical and located in clade B formed by
AB549332 from Tanzania in 2010. Sequence comparison of strains
Table 4
DENV-3 strains from GenBank used in the phylogenetic analysis described in this study
Strain Country Year GenBank Strain Country Year GenBank
HIID02 Indonesia 2005 AB219138 0707aTw Myanmar 2007 EU448443
NIID48 Japan 2008 AB447989 0607aTw Myanmar 2006 EU448444
00510 Ivory Coast 2008 FM213456 0711aTw Bangladesh 2007 EU448445
Hu/08/NIID Tanzania 2010 AB549332 0611aTw Bangladesh 2006 EU448446
Hawaii USA 1945 AF425619 9809aTw Myanmar 1998 EU448447
6805 Saudi Arabia 2004 AM746229 BID-V1736 Puerto Rico 1999 FJ390376
6475 Saudi Arabia 2004 AM746232 SV0837_07 Bhutan 2007 FJ606708
BR74886.02 Brazil 2002 AY679147 ND143 India 2007 FJ644564
Cuba580 Cuba 2001 AY702030 BID-V2328 Thailand 2001 FJ744739
Cuba21 Cuba 2002 AY702031 BID-V2329 Thailand 2001 FJ744740
Cuba116 Cuba 2000 AY702032 BID-V1605 Puerto Rico 2004 FJ850055
PF903050 French Polynesia 1990 AY744679 BID-V2412 Sri Lanka 1989 FJ882572
PF922986 Tahiti 1992 AY744683 BID-V2413 Sri Lanka 1993 FJ882573
FW01 Indonesia 2004 AY858040 BID-V2978 Colombia 2001 GQ199891
KJ30i Indonesia 2004 AY858042 DTID-ZJU04 China 2009 GU189648
KJ71 Indonesia 2004 AY858044 zhengjiang2709 China 2009 GU721068
TB16 Indonesia 2004 AY858047 GZ1D3 China 2009 GU363549
TB55i Indonesia 2004 AY858048 Zhejiang/08/09 China 2009 GU721065
0409aTw Vietnam 2004 DQ518656 Zhejiang/15/09 China 2009 GU721066
0507aTw Vietnam 2005 DQ518658 Zhejiang/17/09 China 2009 GU721067
0308aTw Thailand 2003 DQ518660 Zhejiang/31/09 China 2009 GU721069
9807aTw Thailand 1998 DQ518663 Alto Lucero/5 Mexico 2006 HM171538
0211aTw Thailand 2002 DQ518664 Tlaltizapan/3 Mexico 2006 HM171540
0108aTw Bangladesh 2001 DQ518665 ARU99.1 Aruba 1999 HM348812
0508aTw Myanmar 2005 DQ518666 H50978 Venezuela 2000 HM348813
0508aTw Philippines 2005 DQ518673 H63263 Venezuela 2001 HM348815
Indo9804aTw Indonesia 1998 DQ518676 L6700 Venezuela 2001 HM348817
0312aTw Indonesia 2003 DQ518677 H63788 Venezuela 2001 HM348823
0508aTw Indonesia 2005 DQ518678 H64276 Venezuela 2001 HM348824
9912aTw Sri Lanka 1999 DQ518679 H220034 Venezuela 2003 HM348825
0707aTw Philippines 2007 EU448432 H41302058 Venezuela 2005 HM348828
0608aTw Philippines 2006 EU448433 H413302054 Venezuela 2005 HM348829
0702aTw Indonesia 2007 EU448434 H297222 Venezuela 2007 HM348830
0603aTw Indonesia 2006 EU448435 H298650 Venezuela 2007 HM348831
0508aTw Singapore 2005 EU448436 Lam Dong Vietnam 2010 HQ141582
0302aTw Indonesia 2003 EU448437 BID-V4743 Nicaragua 2009 HQ166034
0710aTw Malaysia 2007 EU448438 BID-V4762 Nicaragua 2009 HQ541797
0610aTw Malaysia 2006 EU448439 DID-V4838 Nicaragua 2009 HQ705619
0609aTw Cambodia 2006 EU448440 BID-V4307 Cambodia 2007 JF295012
0604aTw Vietnam 2006 EU448441 1340 Puerto Rico 1977 L11434
0310aTw Vietnam 2003 EU448442 1339 Puerto Rico 1977 AY146761
80-2 China 1980 AF317645 BS- PRico63 Puerto Rico 1963 AY146762
07CHLS001 China 2007 EU367962 2783 Sri Lanka 1991 L11438
GZ2D3 China 2009 JN662391 MK-315 Thailand 1987 L11442
ZJYW2009 China 2009 JF540679 H-87 Philippines 1956 M93130
DENV-3, dengue virus type 3.
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98.7%) (Table 3), which suggested that they might have originated
from different countries.
All these results suggest that: (1) the re-emergence of DENV-3
in Guangzhou during 2009–2010 may have been initiated by
imported cases; (2) DENV-3 from 2009–2010 were not from the
continuous spread of the same epidemic strain or re-emergence of
the 2009 strains in the 2010 period; (3) there may be more than
one plausible route of entrance of DENV-3 into Guangzhou, i.e.,
three strains from Baiyun District (10/GZ/9119, 10/GZ/9534, and
10/GZ/9721), one strain form Nansha District (10/GZ/5536), and
one strain from Yuexiu District (10/GZ/4898) in 2010 were closely
related to the strain isolated in 2010 from Tanzania; the 2010
strain from Panyu District (10/GZ/10549) was similar to those from
Indonesia (Figure 2). These conclusions are supported by the recent
research ﬁndings of Moi et al.28 and King et al.20
Sequence comparison also revealed that the outbreaks in
Guangzhou and Zhejiang Province (more than 1400 km apart) in
2009 were caused by the same genotype of DENV-3 (Figure 1).
According to the survey results described previously, partial
sequences of the envelope gene of DENV-3 isolated from Zhejiang
Province in 2009 had 99% similarity to that of AM746229, whichwas detected in Jeddah, Saudi Arabia, in 2004.29 However, in our
opinion, the isolates collected from both Guangzhou and Zhejiang
Province in 2009 were more closely related to two Coˆte d’Ivoire
isolates in 2008, one of which was isolated from a Japanese traveler
to Coˆte d’Ivoire (Japan/NIID48/2008/AB447989). Furthermore, the
2010 DENV-3 genotype III isolates (IIIB clade) share genotype and
clade not only with the Tanzania strain but also with the Saudi
Arabia strain (Figure 1). That is to say, both clades (genotype III
clade A and genotype III clade B) share a common ancestral lineage
with the 2004 Saudi Arabia isolate. Clearly, these two clades
evolved separately from a common ancestor originating in Saudi
Arabia. These ﬁndings suggest that DENV-3 subtype III is easily
transmitted among humans and mosquitoes and can adapt
efﬁciently to new areas. Thus, other regions where the climate
is similar to that of Guangzhou and Zhejiang Province (subtropical
monsoon) should be aware of the risk for expansion of these
strains.29
In summary, all these ﬁndings suggest that the repeated
introductions of different genotypes of DENV-3 following
more than one long-distance route through the continent into
Guangzhou was an important cause of the 2009–2010 dengue
epidemics, and that DENV-3 has not become endemic in
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Figure 1. Phylogenetic tree based on the complete envelope gene from 90 DENV-3 strains sampled globally. Isolates that showed higher nucleotide sequence homology but
were adequately represented were removed from the analysis. Hence, the ﬁnal tree only includes 41 representative samples. The evolutionary history was inferred using the
neighbor-joining method with MEGA 4.0 software. Taxon names correspond to ‘GenBank accession number/country/strain/year of isolation’. Main bootstrap values are
shown on the key nodes of the tree. The tree was rooted using DENV-1 strain AF425619. The newly isolated DENV-3 strains in the study are marked with black dots and the
other Chinese DENV-3 isolates taken for comparison are marked with white dots.
L. Luo et al. / International Journal of Infectious Diseases 17 (2013) e498–e504e502
Figure 2. The origin of DENV-3 strains isolated in Guangzhou during 2009–2010. The maps in the boxes represent the Southeast Asia, East Asia, and Africa sub-regions. The
map on the right is an enlargement of Guangzhou City. The seven dots denote DENV-3 strains isolated in 2009; the six stars denote DENV-3 strains isolated in 2010.
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III, have demonstrated higher epidemic potential with regards to
severe DHF epidemics.23,30 Once the transmission cycle is
established locally, genotype III will soon result in dengue
epidemics, even a trans-national dengue pandemic.25,31,32 Thus,
it will be necessary to initiate a high level of airport fever screening
to identify imported dengue cases and to strengthen dengue
virological surveillance to monitor the emergence of DENV strains
with higher epidemic potential.
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